Related Experiment Video

Updated: May 15, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Relationship between genetic variant in pre-microRNA-146a and genetic predisposition to temporal lobe epilepsy: a

Ida Manna1, Angelo Labate, Laura Mumoli

  • 1Institute of Neurological Sciences, National Research Council, Mangone, Cosenza, Italy.

Gene
|December 25, 2012
PubMed

Insights

This study found that the rs2910164 genetic variant in the pre-microRNA-146a gene does not significantly impact the risk or severity of temporal lobe epilepsy (TLE) in an Italian population. Further research into microRNAs and TLE pathogenesis is warranted.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Inflammatory mechanisms are implicated in temporal lobe epilepsy (TLE) pathogenesis.
  • MicroRNAs (miRNAs) are small non-coding RNAs with altered expression in immune diseases and TLE animal models.
  • Understanding miRNA roles in TLE molecular mechanisms is crucial.

Purpose of the Study:

  • To investigate if the pre-miR-146a rs2910164 genetic variant influences TLE susceptibility in an Italian cohort.
  • To assess the association between this variant and TLE clinical characteristics.

Main Methods:

  • Genotyping of 357 TLE patients and 543 healthy controls for the rs2910164 single nucleotide polymorphism (SNP).
  • TaqMan Allelic Discrimination assays on an Applied Biosystems PCR platform.
  • Statistical analysis of genotype and allelic frequencies.

Main Results:

  • No statistically significant differences in genotype or allelic frequencies were observed between TLE patients and controls (p=0.536 and p=0.361).
  • The rs2910164 variant did not correlate with main clinical characteristics of TLE.
  • The study found no significant association between the variant and TLE risk or severity.

Conclusions:

  • The rs2910164 variant in the pre-miR-146a gene is unlikely to be a significant risk factor for developing TLE.
  • This genetic variant does not appear to influence the severity of temporal lobe epilepsy.
  • Further research is needed to elucidate the role of other miRNAs in TLE.

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice09:13

Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice

Published on: July 11, 2025

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...